National Practice Guideline for Use of Medications in Treatment of Addiction Involving Opioid Use

< Back to All Resources

The American Society of Addiction Medicine (ASAM) developed the National Practice Guideline to provide information on evidence-based treatment of opioid use disorder, and addresses all of the FDA-approved medications available to treat addiction involving opioid use and opioid overdose. The Practice Guideline document and related resources address pregnant women.

The website includes the National Practice Guideline document as well as other resources, tools and webinars. The Practice Guideline is primarily intended for clinicians involved in evaluating patients and providing authorization for pharmacological treatments at any level, such as physicians; other healthcare providers; medical educators and faculty for other healthcare professionals in training; and clinical care managers.

Related Topics

  • Medications for Addiction Treatment (MAT)
  • Medical Care
  • Perinatal Provider Toolkit